Skip to main content
Signal8

Li Nan (LN)

SEC insider (Form 3/4/5 filer). CIK 0002131608. Director at Odyssey Therapeutics, Inc. (ODTX). 2 reported Form 4/5 transactions since Sep 2024; latest on May 11, 2026. Located in BOSTON, MA.

Companies Li Nan (LN) has filed insider reports for

  • Odyssey Therapeutics, Inc. (ODTX): Director
Li Nan (LN) profile photo

Li Nan (LN)

CIK: 0002131608

Transaction Breakdown

Open Market Buys (P)1 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Odyssey Therapeutics, Inc. logo
ODTX

Odyssey Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Odyssey Therapeutics, Inc. logo
    ODTX

    Odyssey Therapeutics, Inc.

    May 11, 2026
    Conversion
    Indirect
    1.7M shares-
  • Odyssey Therapeutics, Inc. logo
    ODTX

    Odyssey Therapeutics, Inc.

    May 11, 2026
    Purchase
    Indirect
    1.1M shares at avg. $18.00$20.0M

1-2 of 2